B · Normal
[The Shanghai Stock Exchange terminates the review of the Issuance and Listing of Sykes Biotechnology Co., Ltd. and its sponsor Everbright Securities Co., Ltd. in accordance with the relevant provisions of Article 63 of the Shanghai Stock Exchange Stock Issuance and Listing Review Rules.] On October 8, the Shanghai Stock Exchange terminated its issuance and listing review.
Comments